Xin-Ting Sang (Xinting Sang)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 15

Top Topics

Prognostic Factors

Inflammatory Response

Squamous Cell Carcinoma

Top Venues

Cancer management and research

Journal of hepatocellular carcinoma

Cancer medicine

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xuezhu Wang, Xu Yang, Jingnan Wang, Chengyan Dong, Jie Ding, Meiqi Wu, Yanyu Wang, Haiyan Ding, Hui Zhang, Xin-Ting Sang, Haitao Zhao, Li Huo
Metabolic Tumor Volume Measured by 18 F-FDG PET/CT is Associated with the Survival of Unresectable Hepatocellular Carcinoma Treated with PD-1/PD-L1 Inhibitors Plus Molecular Targeted Agents. Journal of hepatocellular carcinoma 10 (2023)
Bao Jin, Yuxin Wang, Baoluhe Zhang, Haifeng Xu, Xin Lu, Xin-Ting Sang, Wenze Wang, Yilei Mao, Pengxiao Chen, Shun Wang, Zhirong Qian, Yingyi Wang, Shun-Da Du
Immune checkpoint inhibitor-related molecular markers predict prognosis in extrahepatic cholangiocarcinoma. Cancer medicine (2023)
Lejia Sun, Xindi Ke, Ai Guan, Bao Jin, Jiangming Qu, Yinhan Wang, Xiang Xu, Changcan Li, Hang Sun, Hengyi Xu, Gang Xu, Xin-Ting Sang, Yifei Feng, Yueming Sun, Huayu Yang, Yilei Mao
Intratumoural microbiome can predict the prognosis of hepatocellular carcinoma after surgery. Clinical and translational medicine 13 (7) (2023)
Chengpei Zhu, Hu Li, Xiaobo Yang, Shanshan Wang, Yunchao Wang, Nan Zhang, Yanyu Wang, Jingnan Xue, Longhao Zhang, Cong Ning, Xu Yang, Ziyu Xun, Jiashuo Chao, Junyu Long, Xin-Ting Sang, Zhenyu Zhu, Haitao Zhao
Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study. Cancer immunology, immunotherapy : CII (2023)
Jiayi Li, Qiao Chen, Lei Guo, Ji Li, Bao Jin, Xiangan Wu, Yue Shi, Haifeng Xu, Yongchang Zheng, Yingyi Wang, Shun-Da Du, Zhili Li, Xin Lu, Xin-Ting Sang, Yilei Mao
In situ Detecting Lipids as Potential Biomarkers for the Diagnosis and Prognosis of Intrahepatic Cholangiocarcinoma. Cancer management and research 14 (2022)
Junyu Long, Xu Yang, Jin Bian, Dongxu Wang, Anqiang Wang, Yu Lin, Mingjun Zheng, Haohai Zhang, Xin-Ting Sang, Haitao Zhao
Identification of TMB, CD8 T-cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit-toxicity ratio of anti-PD-1/PD-L1 therapy. Clinical and translational medicine 11 (11) (2022)
Bao Jin, Wenmo Hu, Si Su, Haifeng Xu, Xin Lu, Xin-Ting Sang, Huayu Yang, Yilei Mao, Shun-Da Du
The Prognostic Value of Systemic Inflammation Response Index in Cholangiocarcinoma Patients. Cancer management and research 13 (2021)
Lejia Sun, Dongyue Wang, Mengyuan Zhang, Yukai Jin, Bao Jin, Haifeng Xu, Shunda Du, Yiyao Xu, Haitao Zhao, Xin Lu, Xin-Ting Sang, Shouxian Zhong, Huayu Yang, Yilei Mao
Preoperative Immune Prognostic Index Can Predict the Clinical Outcomes of Patients with Gallbladder Cancer: Single-Center Experience. Cancer management and research 12 (2020)
Bo Hu, Xiao-Bo Yang, Xin-Ting Sang
Construction of a lipid metabolism-related and immune-associated prognostic signature for hepatocellular carcinoma. Cancer medicine 9 (20) (2020)
Bo Hu, Xiao-Bo Yang, Xin-Ting Sang
Development and Verification of the Hypoxia-Related and Immune-Associated Prognosis Signature for Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 7 (2020)
Bo Hu, Jian-Zhen Lin, Xiao-Bo Yang, Xin-Ting Sang
Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review. Cell proliferation 53 (3) (2020)
Qiao Chen, Jiayi Li, Bao Jin, Xiangan Wu, Yue Shi, Haifeng Xu, Yongchang Zheng, Yingyi Wang, Shunda Du, Xin Lu, Xin-Ting Sang, Yilei Mao
Prognostic Nomogram That Predicts Overall Survival of Patients with Distal Cholangiocarcinoma After Pancreatoduodenectomy. Cancer management and research 12 (2020)
Bo Hu, Jian-Zhen Lin, Xiao-Bo Yang, Xin-Ting Sang
The roles of mutated SWI/SNF complexes in the initiation and development of hepatocellular carcinoma and its regulatory effect on the immune system: A review. Cell proliferation 53 (4) (2020)
Shi-Tao Jiang, Junwei Zhang, Jin Bian, Lei Zhang, Yiyao Xu, Haitao Zhao, Xin-Ting Sang, Xin Lu
Novel nomograms based on immune and stromal scores for predicting the disease-free and overall survival of patients with hepatocellular carcinoma undergoing radical surgery. Journal of surgical oncology 122 (8) (2020)
Bo Hu, Xiao-Bo Yang, Xin-Ting Sang
Liver graft rejection following immune checkpoint inhibitors treatment: a review. Medical oncology (Northwood, London, England) 36 (11) (2019)